HomeCDTX • NASDAQ
add
Cidara Therapeutics Inc
Previous close
$11.19
Day range
$11.15 - $11.94
Year range
$10.00 - $24.40
Market cap
54.52M USD
Avg Volume
53.42K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 8.46M | -67.58% |
Operating expense | 6.00M | 34.57% |
Net income | -10.33M | -442.71% |
Net profit margin | -122.01 | -1,157.28% |
Earnings per share | -2.28 | -480.00% |
EBITDA | -10.66M | -478.78% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 29.02M | -39.52% |
Total assets | 52.72M | -35.50% |
Total liabilities | 70.50M | 28.41% |
Total equity | -17.78M | — |
Shares outstanding | 4.56M | — |
Price to book | -2.87 | — |
Return on assets | -44.64% | — |
Return on capital | 324.64% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -10.33M | -442.71% |
Cash from operations | -6.64M | 39.03% |
Cash from investing | -23.00K | 75.53% |
Cash from financing | -93.00K | -100.35% |
Net change in cash | -6.76M | -144.34% |
Free cash flow | -733.88K | 96.65% |
About
Founded
2012
Headquarters
Website
Employees
69